GLAXO — GlaxoSmithKline Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for GlaxoSmithKline Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	28,309	16,541	18,568	24,981	28,211
Net Total Accounts Receivable
Net Total Receivables	3,052	3,419	3,720	3,848	2,731
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	37,080	24,943	27,984	34,099	36,062
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3,254	3,151	3,107	2,839	3,064
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	46,333	33,266	35,566	41,081	43,239
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	16,984	13,264	15,249	19,052	17,791
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	19,703	15,853	17,790	21,568	20,565
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	26,630	17,413	17,776	19,513	22,674
Total Liabilities & Shareholders' Equity	46,333	33,266	35,566	41,081	43,239
Total Common Shares Outstanding